NanoViricides Has Filed its Quarterly Report

2d ago, source:

Additional information regarding the NanoViricides Platform Technology, and the NanoViricides Drug Pipeline can be found in ...

A Novel Broad-Spectrum Antiviral with Activity Against RSV

2d ago, source:

Complete Survival of Animals Lethally Infected into Lungs with RSV Achieved Upon NV-387 Oral Treatment SHELTON, CT / ACCESSWIRE / May 14, 2024 / ...

NanoViricides: Fiscal Q3 Earnings Snapshot

1d ago, source:

NanoViricides Inc. (NNVC) on Wednesday reported a loss of $1.9 million in its fiscal third quarter. On a per-share basis, the ...

NanoViricides to Participate in the 2024 EF Hutton Annual Global Conference On May 15 in New York City

6d ago, source:

NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), a global leader in broad-spectrum antiviral nanomedicines, today ...

Nanoviricides Inc NNVC

8d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

NanoViricides, Inc.: A Novel Broad-Spectrum Antiviral with Activity Against Smallpox/Mpox

8d ago, source:

NV-387 Possesses Strong Orthopoxvirus Activity Relevant to Both Sexual and Inhalation Modes of Transmission, Says NanoViricides SHELTON, CT / ACCESSWIRE / May 8, 2024 / NanoViricides, Inc. (NYSE Ameri ...

A Novel Broad-Spectrum Antiviral with Activity Against Influenza A

11d ago, source:

NV-387 Possesses Strong Anti-Influenza-A Virus Activity, and May Have Activity Against H5N1 Bird Flu Virus, Says ...

NanoViricides to Participate in the 2024 EF Hutton Annual Global Conference On May 15 in New York City

7d ago, source: Eagle-Tribune

For more information visit efhutton.com. NanoViricides, Inc. (the "Company") ( www.nanoviricides.com) is a development stage company that is creating special purpose nanomaterials for antiviral ...

NanoViricides to Participate in the 2024 EF Hutton Annual Global Conference On May 15 in New York City

7d ago, source: The Olympian

SHELTON, CT / ACCESSWIRE / May 10, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a global leader in broad-spectrum antiviral nanomedicines, today announces that Anil R.